Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII
about
Therapies for the bone in mucopolysaccharidosesNewborn screening and diagnosis of mucopolysaccharidosesCNS-directed gene therapy for the treatment of neurologic and somatic mucopolysaccharidosis type II (Hunter syndrome)The effect of neonatal gene therapy on skeletal manifestations in mucopolysaccharidosis VII dogs after a decade.Characterization of the MPS I-H knock-in mouse reveals increased femoral biomechanical integrity with compromised material strength and altered bone geometryEstablishment of glycosaminoglycan assays for mucopolysaccharidosesEnzyme replacement therapy in newborn mucopolysaccharidosis IVA mice: early treatment rescues bone lesions?Newborn screening and diagnosis of mucopolysaccharidoses: application of tandem mass spectrometry.Molecular Genetics and Metabolism Report Long-term follow-up of post hematopoietic stem cell transplantation for Hurler syndrome: clinical, biochemical, and pathological improvements.Neonatal bone marrow transplantation prevents bone pathology in a mouse model of mucopolysaccharidosis type I.The effect of Tlr4 and/or C3 deficiency and of neonatal gene therapy on skeletal disease in mucopolysaccharidosis VII mice.Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB.Assessment of bone mineral density by dual energy x-ray absorptiometry in patients with mucopolysaccharidosesReview of clinical presentation and diagnosis of mucopolysaccharidosis IVAProgressive neurologic and somatic disease in a novel mouse model of human mucopolysaccharidosis type IIIC.Long-term nonsense suppression therapy moderates MPS I-H disease progression.Mucopolysaccharidosis IVA and glycosaminoglycans.Liver-Directed Human Amniotic Epithelial Cell Transplantation Improves Systemic Disease Phenotype in Hurler Syndrome Mouse Model.Pathogenesis and treatment of spine disease in the mucopolysaccharidoses.Disease correction by AAV-mediated gene therapy in a new mouse model of mucopolysaccharidosis type IIID.Measurement of Elevated Concentrations of Urine Keratan Sulfate by UPLC-MSMS in Lysosomal Storage Disorders (LSDs): Comparison of Urine Keratan Sulfate Levels in MPS IVA Versus Other LSDs.Postnatal progression of bone disease in the cervical spines of mucopolysaccharidosis I dogs.Neonatal umbilical cord blood transplantation halts skeletal disease progression in the murine model of MPS-I.Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I.Newborn screening for mucopolysaccharidoses: a pilot study of measurement of glycosaminoglycans by tandem mass spectrometry.
P2860
Q26852308-265500D4-344E-4F0A-957E-0A846A739A7AQ27025080-35AB7219-5EC9-49C5-BCBF-077FAFD215B2Q27333793-390D4FCD-F66D-4E48-9C4D-2B5954B5B438Q30540876-C9EAEEA9-082E-40C4-BF42-AA5001B227C6Q33800106-8F859DF7-8DFF-4CEE-A322-B9E88755C44FQ34318230-24A1F0A0-BD19-473F-87E1-5F78FE383B23Q34633246-E0FEA4FD-6536-4C6E-968F-DBE7C06B0F40Q35000585-9E943018-EC2D-4384-92EA-47A4E58A6E8AQ35104361-BA686041-51D0-43AD-8F1A-FA8EC5EF4CEDQ35153234-ADDEEB96-63C8-4247-9947-182C6CBCBDF9Q35237967-4C9F497E-AFB4-4D4B-9B62-499B7B00521CQ35752500-8E7AF1BE-FA98-4930-B91F-5F618B08C095Q36972323-F02C54B1-ABE6-41DF-817B-80D8198C8781Q37126295-150CDB0F-3375-47CD-8232-D77FEAC2097FQ37305882-48F34512-47C1-4FC4-BCD3-E619C4979381Q37619694-78ED5865-A9CD-4457-8303-AAF3EAF3E41DQ37626886-E06EBFEE-076E-4892-846A-66587DE8CEA8Q38741428-2DB4A317-1BB8-4D8E-888E-069819FD72B6Q38853824-6B0F54FB-75F4-4E86-B540-E26D39E3B261Q40277701-C58DEEF6-4E29-4824-A2CA-402E338A2D1FQ41009106-BD379582-6B16-4943-ABC5-612E8254372DQ41273646-399E89BC-C22F-407D-9593-3249E18AD99CQ41533871-8BEE89C7-9FAA-4A3C-BFEC-26FCB66CE204Q45879685-5BC03A7F-7601-43C9-B03B-6263DCC1C705Q48484381-98E93A7E-C9A4-4975-8055-5E616D03A482
P2860
Assessment of bone dysplasia by micro-CT and glycosaminoglycan levels in mouse models for mucopolysaccharidosis type I, IIIA, IVA, and VII
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Assessment of bone dysplasia b ...... sis type I, IIIA, IVA, and VII
@ast
Assessment of bone dysplasia b ...... sis type I, IIIA, IVA, and VII
@en
type
label
Assessment of bone dysplasia b ...... sis type I, IIIA, IVA, and VII
@ast
Assessment of bone dysplasia b ...... sis type I, IIIA, IVA, and VII
@en
prefLabel
Assessment of bone dysplasia b ...... sis type I, IIIA, IVA, and VII
@ast
Assessment of bone dysplasia b ...... sis type I, IIIA, IVA, and VII
@en
P2093
P2860
P1476
Assessment of bone dysplasia b ...... sis type I, IIIA, IVA, and VII
@en
P2093
Adriana M Montaño
Daniel J Rowan
Jeffrey H Grubb
Shunji Tomatsu
William S Sly
P2860
P2888
P304
P356
10.1007/S10545-012-9522-X
P577
2012-09-13T00:00:00Z